Bioventus Inc. (BVS) is a Healthcare stock trading at $8.72 (as of 2026-06-18), with a market capitalization of $567.77M and a trailing P/E of 20.8. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Bioventus Inc. is a medical device company focused on developing and commercializing clinical treatment solutions intended to support the body’s natural healing. Its portfolio spans pain therapies (including non-surgical joint injections), surgical products (such as bone graft substitutes and ultrasonic devices), and restorative and rehabilitation offerings used across orthopedic and related care settings by physicians in clinics, ambulatory centers, and hospitals.